Chris Vazquez, Chief Accounting Officer at Biodesix Inc. ($BDSX), sold shares on the open market seven times over the past year, totaling about $4,700. His most recent sale occurred on February 23, 2026. These sales rank 11,414th among 11,678 insiders in our database, where the average is $8.6 million across 6.4 transactions per person. Vazquez made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 20, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 563 | $0.00 | 1,689.0000 | 7,954,541 | 25.00% | 0.01% |
| Feb. 20, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 563 | $0.00 | 1,797.0000 | 7,954,541 | 45.62% | 0.01% |
| Feb. 23, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 211 | $12.78 | 1,586.0000 | 7,954,541 | 11.74% | 0.00% |
| Feb. 9, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 235 | $0.00 | 234.0000 | 7,954,541 | 50.11% | 0.00% |
| Feb. 9, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 28 | $0.00 | 0.0000 | 7,954,541 | 100.00% | 0.00% |
| Feb. 9, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 263 | $0.00 | 1,335.0000 | 7,954,541 | 24.53% | 0.00% |
| Feb. 10, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 101 | $10.08 | 1,234.0000 | 7,954,541 | 7.57% | 0.00% |
| Jan. 15, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 219 | $0.00 | 1,155.0000 | 7,954,541 | 23.40% | 0.00% |
| Jan. 15, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 219 | $0.00 | 436.0000 | 7,954,541 | 33.44% | 0.00% |
| Jan. 16, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 83 | $8.15 | 1,072.0000 | 7,954,541 | 7.19% | 0.00% |
| Jan. 2, 2026 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Stock Options (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 7,954,541 | 9999.99% | 0.15% |
| Nov. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 31 | $0.00 | 949.0000 | 7,954,541 | 3.38% | 0.00% |
| Nov. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 13 | $7.62 | 936.0000 | 7,954,541 | 1.37% | 0.00% |
| Nov. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 31 | $0.00 | 29.0000 | 7,954,541 | 51.67% | 0.00% |
| Aug. 12, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 602 | $0.00 | 1,203.0000 | 145,491,569 | 33.35% | 0.00% |
| Aug. 12, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 602 | $0.00 | 18,603.0000 | 145,491,569 | 3.34% | 0.00% |
| Aug. 13, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 228 | $0.42 | 18,375.0000 | 145,491,569 | 1.23% | 0.00% |
| May 9, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 602 | $0.00 | 1,805.0000 | 145,491,569 | 25.01% | 0.00% |
| May 9, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 602 | $0.00 | 18,225.0000 | 145,491,569 | 3.42% | 0.00% |
| May 12, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 112 | $0.36 | 18,113.0000 | 145,491,569 | 0.61% | 0.00% |
| May 13, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 112 | $0.35 | 18,001.0000 | 145,491,569 | 0.62% | 0.00% |
| Feb. 20, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Restricted Stock Units | 45050 | $0.00 | 45,050.0000 | 145,491,569 | 9999.99% | 0.03% |
| Feb. 20, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Stock Options (Right to buy) | 90100 | $0.00 | 90,100.0000 | 145,491,569 | 9999.99% | 0.06% |
| Feb. 20, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Stock Options (Right to buy) | 39664 | $0.00 | 39,664.0000 | 145,491,569 | 9999.99% | 0.03% |
| Feb. 11, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 3630 | $0.92 | 17,623.0000 | 145,491,569 | 17.08% | 0.00% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 4694 | $0.00 | 9,388.0000 | 145,491,569 | 33.33% | 0.00% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 601 | $0.00 | 2,407.0000 | 145,491,569 | 19.98% | 0.00% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 4371 | $0.00 | 13,112.0000 | 145,491,569 | 25.00% | 0.00% |
| Feb. 10, 2025 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 9666 | $0.00 | 21,253.0000 | 145,491,569 | 83.42% | 0.01% |
| Nov. 11, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 105 | $1.39 | 11,685.0000 | 96,235,883 | 0.89% | 0.00% |
| Nov. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 602 | $0.00 | 3,008.0000 | 96,235,883 | 16.68% | 0.00% |
| Nov. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 602 | $0.00 | 11,790.0000 | 96,235,883 | 5.38% | 0.00% |
| Nov. 12, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 98 | $1.40 | 11,587.0000 | 96,235,883 | 0.84% | 0.00% |
| Aug. 12, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 54 | $1.57 | 11,188.0000 | 96,235,883 | 0.48% | 0.00% |
| Aug. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 602 | $0.00 | 3,610.0000 | 96,235,883 | 14.29% | 0.00% |
| Aug. 9, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 155 | $1.60 | 11,242.0000 | 96,235,883 | 1.36% | 0.00% |
| Aug. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 602 | $0.00 | 11,397.0000 | 96,235,883 | 5.58% | 0.00% |
| May 23, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Series A Non-Voting Convertible Preferred Stock | 22 | $0.00 | 0.0000 | 96,235,883 | 100.00% | 0.00% |
| May 23, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 880 | $0.00 | 10,795.0000 | 96,235,883 | 8.88% | 0.00% |
| May 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 601 | $0.00 | 10,159.0000 | 96,235,883 | 6.29% | 0.00% |
| May 9, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 244 | $1.48 | 9,915.0000 | 96,235,883 | 2.40% | 0.00% |
| May 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 601 | $0.00 | 4,212.0000 | 96,235,883 | 12.49% | 0.00% |
| April 5, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Series A Non-Voting Convertible Preferred Stock | 22 | $46.00 | 22.0000 | 96,235,883 | 9999.99% | 0.00% |
| Feb. 21, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Stock Options (Right to buy) | 14280 | $0.00 | 14,280.0000 | 96,235,883 | 9999.99% | 0.01% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Common Stock | 5296 | $0.00 | 11,547.0000 | 96,235,883 | 84.72% | 0.01% |
| Feb. 9, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 1077 | $1.92 | 10,470.0000 | 96,235,883 | 9.33% | 0.00% |
| Feb. 12, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | S | Common Stock | 922 | $1.66 | 9,548.0000 | 96,235,883 | 8.81% | 0.00% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Restricted Stock Units | 17483 | $0.00 | 17,483.0000 | 96,235,883 | 9999.99% | 0.02% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | A | Stock Options (Right to buy) | 34966 | $0.00 | 34,966.0000 | 96,235,883 | 9999.99% | 0.04% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 602 | $0.00 | 4,813.0000 | 96,235,883 | 11.12% | 0.00% |
| Feb. 8, 2024 | BIODESIX INC | $BDSX | Vazquez Chris | Chief Accounting Officer | M | Restricted Stock Units | 4694 | $0.00 | 14,082.0000 | 96,235,883 | 25.00% | 0.00% |